Consolidated Statements of Income (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Jan. 23, 2026	Jan. 24, 2025	Jan. 23, 2026	Jan. 24, 2025
Income Statement [Abstract]
Net sales	$ 9,017	$ 8,292	$ 26,557	$ 24,610
Costs and expenses:
Cost of products sold, excluding amortization of intangible assets	3,261	2,779	9,323	8,485
Research and development expense	722	675	2,202	2,048
Selling, general, and administrative expense	2,956	2,717	8,727	8,129
Amortization of intangible assets	441	416	1,364	1,243
Restructuring charges, net	77	43	131	120
Certain litigation charges, net	62	22	89	104
Other operating expense (income), net	35	(5)	126	(38)
Operating profit	1,464	1,646	4,594	4,519
Other non-operating income, net	(121)	(72)	(247)	(403)
Interest expense, net	181	179	539	555
Income before income taxes	1,404	1,540	4,302	4,367
Income tax provision	254	237	724	737
Net income	1,150	1,303	3,578	3,630
Net income attributable to noncontrolling interests	(6)	(9)	(21)	(24)
Net income attributable to Medtronic	$ 1,143	$ 1,294	$ 3,557	$ 3,606
Basic earnings per share (in dollars per share)	$ 0.89	$ 1.01	$ 2.77	$ 2.80
Diluted earnings per share (in dollars per share)	$ 0.89	$ 1.01	$ 2.76	$ 2.79
Basic weighted average shares outstanding (in shares)	1,282.6	1,282.4	1,282.1	1,286.7
Diluted weighted average shares outstanding (in shares)	1,289.5	1,286.2	1,288.2	1,290.6